EventsThe 1st International Online Conference on Bioengineering
Published
This submission belongs to the session 3. Biomedical Biomaterials of the event The 1st International Online Conference on Bioengineering
Published date
11 Oct, 2024
Academic Editor
author-avatarGary Bowlin
Citation
Amina Voznyuk, Elizaveta Koudan, Layer-by-layer assembly for manufacturing local chemotherapy platforms with controlled and sustained drug release to prevent local tumor relapse, in Proceedings of The 1st International Online Conference on Bioengineering, 16 October–18 October 2024, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Layer-by-layer assembly for manufacturing local chemotherapy platforms with controlled and sustained drug release to prevent local tumor relapse

Elizaveta Koudan 1
1. National University of Science and Technology MISIS, 119049, Leninskiy pr. 4, Moscow, Russia, Russia
Abstract

Introduction: Layer-by-layer (LbL) assembly is characterized by controlled and prolonged drug release over 3 months compared to electrospinning or solvent casting methods, making it a promising approach for local chemotherapy platforms. The aim of this research was to develop local chemotherapy platforms using different layer-by-layer assembly methods to identify the most efficient drug encapsulation and to achieve the uniform and sustained drug release kinetics.

Methods: The platform developed in this study consists of a polycaprolactone substrate and a multilayer coating produced by LbL assembly. The coating contains the chemotherapeutic drug doxorubicin (DOX), which was stabilized for release by preforming an ionic complex between poly-γ-glutamic acid and DOX, which was then used as a polyanion during LbL assembly. Different LbL assembly methods (by spin or dip), various polycations and the addition of DOX-unloaded polyelectrolyte bilayers were examined. The drug release mechanism was studied in vitro in PBS, mimicking the natural environment of physiological fluids with pH 7.4 at 37 °С. The platforms were also tested for the in vitro antitumor activity of DOX using ovarian cancer cells (SKOV-3).

Results: DOX release from the obtained platforms was sustained for over 6 months with minimal burst kinetics and uniformity, but the drug encapsulation in LbL assembly by spin was tenfold higher. Dip-coated platforms had a coefficient of determination (R2) of 0.84, while spin-coated platforms had an R2 of 0.94, when compared to a zero-order drug release model. The in vitro studies showed that the platform has no effect on the antitumor activity of DOX.

Conclusions: This work is encouraging for the development of drug delivery systems as it demonstrates the potential of spin-assisted assembly, offsetting the explosive nature of drug release, and showing its highest stability compared to similar studies.

Keywords
cancer therapy
local chemotherapy
controlled drug release
biodegradable materials
doxorubicin
layer-by-layer assembly
multilayer coating
Mitigating Human Error in Breast Cancer Diagnosis with Deep Learning
Effect of Data Collection and Environment on Machine Learning Performance in Screening Dysphonia